This document summarizes the updated NICE guidance for the diagnosis and comprehensive management of chronic heart failure in adults.
Clinicians should adopt updated NICE recommendations for chronic HF management; extends 2010 guidance with new evidence on MRAs, monitoring, and multidisciplinary care.
The prevalence of heart failure is increasing because of an ageing population and improved survival of chronic diseases that contribute to heart failure. Heart failure includes reduced ejection fraction (≺40%) and preserved ejection fraction (≻50%) disease. The National Institute for Health and Care Excellence (NICE) guideline on chronic heart failure was last updated in 2010. Since then, further evidence on novel and existing therapies, for example mineralocorticoid receptor antagonists (MRAs), has emerged. New research has also been published on diagnosing heart failure and approaches to heart failure care, including monitoring, rehabilitation, and the composition of the multidisciplinary team.
No takes yet. Share an insight, caveat, or question.
Real et al. (2018) conducted a review in Chronic heart failure. Updated NICE guidance was evaluated. The updated NICE guideline on chronic heart failure incorporates new evidence on therapies like mineralocorticoid receptor antagonists, diagnosis, monitoring, and multidisciplinary team care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: